NDT Plus Advance Access originally published online on February 14, 2008
NDT Plus 2008 1(2):112-116; doi:10.1093/ndtplus/sfn006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Tubulointerstitial nephritis and uveitis (TINU) syndrome: epidemiology, diagnosis and management
1 Nephrology Unit, Antrim Area Hospital, 45 Bush Road, Antrim, BT41 2RL
2 Regional Nephrology Unit
3 Department of Pathology, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, UK
Correspondence: Kim Sinnamon, Nephrology Unit, Antrim Area Hospital, 45 Bush Road, Antrim, BT41 2RL, Northern Ireland, UK. Tel: +44-2894424000; Fax: +44-2894424883; E-mail: kimsinnamon@msn.com
Key Words: corticosteroids tubulointerstitial nephritis uveitis
Received for publication August 30, 2007. Accepted for publication January 9, 2008.
| The first 150 words of the full text of this article appear below. |
| Introduction |
|---|
Acute tubulointerstitial nephritis is demonstrated in 2–3% of all native renal biopsies, increasing to 10–15% if the biopsy is performed in the setting of acute renal failure [1]. It is most commonly related to medication or infection [1,2]. An increasingly recognized entity is tubulointerstitial nephritis with uveitis (TINU) syndrome. We outline the clinical course of a patient with TINU syndrome and review the changes in epidemiology, diagnosis and management.
| Case |
|---|
A 39-year-old man presented with a 6-month history of lethargy and generalized arthralgia. He also complained of urinary frequency and nocturia. His renal function was impaired with a creatinine of 257 µmol/L (estimated glomerular filtration rate, eGFR, 28 mls/min). He had received topical treatment for sudden-onset bilateral anterior uveitis 6 weeks previously but had no other significant past medical history. He took no regular medications and there had been no use of antibiotics or non-steroidal agents in
| Discussion |
|---|
Epidemiology
Pathophysiology
Clinical features
Management
| Teaching points |
|---|